Drawbridge is a privately-held company head quartered in Melbourne, Australia. Drawbridge is developing neuroactive steroid compounds for use in critical care situations in which protection of the brain from insult is required. Phaxan™ is the lead compound for use as a fast onset and offset intraven...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2010 (14 years) |
Funding status Private |
Company type SME |
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Executive Director, Founder and Chief Medical Officer | hidden.item | hidden.item | hidden.item |